PUBLISHER: Grand View Research | PRODUCT CODE: 1493484
PUBLISHER: Grand View Research | PRODUCT CODE: 1493484
The global artificial heart market size is expected to reach USD 5.94 billion by 2030, registering a CAGR of 11.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by various factors such as the increasing burden of cardiovascular diseases, technological advancements in the field, a growing geriatric population, and lifestyle changes leading to higher cardiovascular risks. As the global population ages, there is an increased incidence of cardiac issues among older individuals. This demographic trend contributes to the demand for artificial hearts as a treatment option for heart failure and other conditions.
The global burden of CVDs is increasing, driven by the aging population, sedentary lifestyles, and unhealthy diets. According to an article by NCBI in May 2022, 92.1 million Americans are affected by some form of CVD, and it is predicted that 43.9% will have some type of CVD by 2030. Similarly, according to the British Heart Foundation's July 2022 report, 4 million men and 3.6 million women lived with heart and circulatory diseases in 2021. Continued investment in research aimed at improving cardiac patient outcomes drives adoption rates for artificial hearts. In January 2024, CARMAT introduced a new software enhancement for its artificial heart Aeson, aiming to enhance its safety profile by enabling real-time defect detection and modifying control to provide continuous patient care.